GlassScriptPhysician profile
Andrew Roden
NPI 1881145654
$1,041.37
in general payments reported to CMS, 2019-2025
25 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $110 · 2022: $158 · 2023: $269 · 2024: $202 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $773.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $399.00 | 2021-2025 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $96.80 | 2023-2024 | Zilretta, Iovera, Exparel |
| Djo, LLC | $62.69 | 2025 | Cmf |
| Horizon Therapeutics Plc | $56.16 | 2021-2023 | Krystexxa |
| Amgen INC. | $38.62 | 2023-2024 | Krystexxa, Evenity, Prolia |
| Heron Therapeutics, INC. | $32.14 | 2022 | |
| Abbvie INC. | $31.68 | 2021-2025 | |
| Avanos Medical | $28.73 | 2023 | Genvisc 850 Sodium Hyaluronate |
| Mallinckrodt Hospital Products INC. | $23.91 | 2024 | Acthar |
| Boston Scientific Corporation | $23.80 | 2023 | Wavewriter Alpha Prime 16 |
| Otsuka America Pharmaceutical, INC. | $21.38 | 2023 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $20.97 | 2025 | Wainua |
| Seqirus USA INC | $19.96 | 2022 | |
| Nevro Corp. | $19.79 | 2023 | Senza |
| Radius Health, INC. | $19.43 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18.19 | 2024 | Kyphon Express II Kyphopak Tray |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.10 | 2025 | Xifaxan |
| Exact Sciences Corporation | $15.95 | 2023 | Cologuard Collection Kit |
| Alpha Orthopedic Systems | $15.53 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.97 | 2025 | Caplyta |
| Smith+Nephew, INC. | $14.68 | 2025 | Pico 14 |
| Vertex Pharmaceuticals Incorporated | $14.30 | 2025 | |
| Bioventus LLC | $14.19 | 2025 | Exogen Ultrasound Bone Healing System |
| Axsome Therapeutics, INC. | $13.91 | 2025 | Auvelity |
| Orthofix Medical, INC. | $8.49 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Roden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.